Abstracts - PAGE Meeting (Population Approach Group Europe)

← Back to filters

Abstracts (27)

I-17Leticia Arrington

An R package for Automated Generation of Item Response Theory Model NONMEM Control File

Wednesday 09:50-11:15

I-20Magnus Åstrand

nonmem2R: An R-package for Visual Predictive Checks and Goodness-of-fit Plots

Wednesday 09:50-11:15

I-26Junjie Ding

Pharmacometric drug adherence approach and its application in a clinical setting

Wednesday 09:50-11:15

I-41Julie Bertrand

Model-based approach for group sequential and adaptive designs in parallel and cross-over bioequivalence studies

Wednesday 09:50-11:15

I-42Robert Bies

On the Multilemma of reproducibility: Stochastic or Deterministic or Stochastic and Deterministic

Wednesday 09:50-11:15

I-46Guillaume Bonnefois

A new computational approach to match control subjects to renal impaired patients in pharmacokinetic studies

Wednesday 09:50-11:15

I-54Vincent Buchheit

Data scientists for improving efficiency and quality of quantitative clinical pharmacology analyses

Wednesday 09:50-11:15

II-02Markus Krauß

Mice with human livers improve First-in-Human prediction of pharmacokinetics

Wednesday 15:10-16:40

II-03Rukmini Kumar

Quantitative Systems Pharmacology (QSP) tools to aid in model development and communication: Vantage QSP Modeling Tools (VQM-Tools)

Wednesday 15:10-16:40

II-14So Jin Lee

The new era of pharmacokinetic/pharmacodynamic modeling and simulation in drug development in Korea

Wednesday 15:10-16:40

II-18Yisheng Li

A semi-mechanistic dose-finding design in oncology using pharmacokinetic/pharmacodynamic modeling

Wednesday 15:10-16:40

II-29Nicolas Luyckx

Improving the performances of clinical trial simulations in Simulo using compiled code

Wednesday 15:10-16:40

II-30Yassine Kamal Lyauk

Dose Finding in Clinical Development of 60 FDA-Approved Drugs Compared to the Learning versus Confirming Paradigm

Wednesday 15:10-16:40

II-72Nathalie Perdaems

Translational PK-RO modelling for a mAb to predict the outcome of the first in human study

Wednesday 15:10-16:40

III-22Jaydeep Sinha

Extension of the Janmahasatian fat-free mass model to account for ethnicity-related bias

Thursday 09:55-11:20

III-24Eunjung Song

Selection of optimal study design based on the bioequivalence simulation study in highly variable drugs

Thursday 09:55-11:20

III-44Pauline Traynard

New library of double absorptions PK models for the MonolixSuite, application to veralipride pharmacokinetics

Thursday 09:55-11:20

III-74Sebastian Wicha

TDMxR: an open-source package for model-based therapeutic drug monitoring in R

Thursday 09:55-11:20

III-79Dan Wright

Kinetic-pharmacodynamic models in the setting of non-linear drug elimination

Thursday 09:55-11:20

III-87Yang Zhang

Ways to improve the efficiency of pharmacometric model implemented in R using deSovle – an example with a PK model for ADC

Thursday 09:55-11:20

IV-06Dimitra Eleftheriadou

Aluminium biokinetics: Elucidating the speciation kinetics of the aluminium-citrate system in vitro.

Thursday 15:25-16:50

IV-16Valentina Fermanelli

Correlation structure of Apolipoprotein A4, C3, E kinetics parameters

Thursday 15:25-16:50

IV-33Mario Gonzalez Sales

Assembling pharmacometric datasets in R: the puzzle package

Thursday 15:25-16:50

IV-47Charlotte Kloft

Review of NMLE articles published in clinical journals with a higher impact factor

Thursday 15:25-16:50

IV-69Fabian Jung

Simulation of the environmental exposure to fenofibrate nanomaterials based on in vitro- and in silico methods

Thursday 15:25-16:50

IV-71Evangelos Karakitsios

A methodology to estimate population pharmacokinetic parameters from aggregate concentration-time data and its application to gevokizumab.

Thursday 15:25-16:50

IV-73Eleni Karatza

Investigation of the impact of population parameters describing gastric emptying on bioequivalence metrics

Thursday 15:25-16:50